Skip to main content
. 2018 Dec 27;15:127–135. doi: 10.2147/NDT.S186865

Figure 2.

Figure 2

Meta-analysis on clinical outcomes (SMD estimates [95% CI]) for GOS (A) and mRS (B) scores for patients treated with cerebrolysin and control groups.

Note: Weights are from random-effects analysis.

Abbreviations: GOS, Glasgow Outcome Scale; mRS, modified Rankin Scale; SMD, standardized mean difference.